AURKA induces EMT by regulating histone modification through Wnt/β-catenin and PI3K/Akt signaling pathway in gastric cancer

Gastric cancer, a highly invasive and aggressive malignancy, is the third leading cause of death from cancer worldwide. Genetic association studies have successfully revealed several important genes consistently associated with gastric cancer to date. However, these robust gastric cancer-associated genes do not fully elucidate the mechanisms underlying the development and progression of the disease. In the present study, we performed an alternative approach, a gene expression-based genome-wide association study (eGWAS) across 13 independent microarray experiments (including 251 gastric cancer cases and 428 controls), to identify top candidates (p<0.00001). Additionally, we conducted gene ontology analysis, pathway analysis and network analysis and identified aurora kinase A (AURKA) as our candidate. We observed that MLN8237, which is a specific inhibitor of AURKA, decreased the β-catenin and the phosphorylation of Akt1 and GSK-3β, as well as blocked the Akt and Wnt signaling pathways. Furthermore, MLN8237 arrested the cells in the G2/M phase. The activity of Wnt and Akt signaling pathways affected the level of histone methylation significantly, and we supposed that MLN8237 affected the level of histone methylation through these two signaling pathways. Additionally, the treatment of MLN8237 influenced the level of H3K4 me1/2/3 and H3K27 me1/2/3. Chip data on cell lines suggested that MLN8237 increases the level of H3K27 me3 on the promoter of Twist and inhibits EMT (epithelial-mesenchymal transition). In summary, AURKA is a potential therapeutic target in gastric cancer and induces EMT through histone methylation.

[1]  D. Forman,et al.  The fight against gastric cancer - the IARC Working Group report. , 2014, Best practice & research. Clinical gastroenterology.

[2]  S. Weroha,et al.  Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Yongli Yue,et al.  Epigenetic reprogramming of human lung cancer cells with the extract of bovine parthenogenetic oocytes , 2014, Journal of cellular and molecular medicine.

[4]  A. Laenkholm,et al.  A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells , 2014, Oncogene.

[5]  B. Geiger,et al.  Excess β‐catenin promotes accumulation of transcriptionally active p53 , 1999, The EMBO journal.

[6]  Sejong Oh,et al.  Epidemiological and Genome-Wide Association Study of Gastritis or Gastric Ulcer in Korean Populations , 2014, Genomics & informatics.

[7]  C. Prigent,et al.  Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases. , 1999, Journal of cell science.

[8]  Domenico Coppola,et al.  Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  Li-hui Wang,et al.  SMAD4 Suppresses AURKA-Induced Metastatic Phenotypes via Degradation of AURKA in a TGFβ-Independent Manner , 2014, Molecular Cancer Research.

[10]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[11]  Xia Li,et al.  JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma. , 2014, Neuro-oncology.

[12]  P. Polakis.  The oncogenic activation of beta-catenin. , 1999, Current opinion in genetics & development.

[13]  G. Jin,et al.  Functional polymorphism rs4072037 in MUC1 gene contributes to the susceptibility to gastric cancer: evidence from pooled 6,580 cases and 10,324 controls , 2013, Molecular Biology Reports.

[14]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[15]  Shufeng Zhou,et al.  The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells , 2015, Drug design, development and therapy.

[16]  M. Shin,et al.  Common genetic variants at 1q22 and 10q23 and gastric cancer susceptibility in a Korean population , 2014, Tumor Biology.

[17]  Elvis Valderrama,et al.  Association of common variants on chromosome 8q24 with gastric cancer in Venezuelan patients. , 2015, Gene.

[18]  R. Weinberg,et al.  AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment. , 2010, Cancer research.

[19]  A. Dar,et al.  The Aurora kinase A Regulates GSK-3β in Gastric Cancer Cells , 2008, Oncogene.

[20]  Wen Tan,et al.  A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1 , 2011, Nature Genetics.

[21]  M. Dawson,et al.  Cancer Epigenetics: From Mechanism to Therapy , 2012, Cell.

[22]  Tong Tong,et al.  Overexpression of Aurora-A Contributes to Malignant Development of Human Esophageal Squamous Cell Carcinoma , 2004, Clinical Cancer Research.

[23]  Teruhiko Yoshida,et al.  Genetic factors related to gastric cancer susceptibility identified using a genome‐wide association study , 2013, Cancer science.

[24]  Tao Jiang,et al.  Nuclear Translocation of β-catenin is Essential for Glioma Cell Survival , 2012, Journal of Neuroimmune Pharmacology.

[25]  Huan Yang,et al.  Aurora‐A induces cell survival and chemoresistance by activation of Akt through a p53‐dependent manner in ovarian cancer cells , 2006, International journal of cancer.

[26]  Paul Polakis,et al.  The oncogenic activation of β-catenin , 1999 .

[27]  Jian Kuang,et al.  Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation , 1998, Nature Genetics.

[28]  Massimo Broggini,et al.  Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. , 2012, Cancer treatment reviews.

[29]  H. Katai,et al.  Present and future status of gastric cancer surgery. , 2011, Japanese journal of clinical oncology.

[30]  K. Pooley,et al.  Genetic variation and gastric cancer risk: a field synopsis and meta-analysis , 2015, Gut.

[31]  Robert R. Klein,et al.  Aurora‐A over‐expression in high‐grade PIN lesions and prostate cancer , 2005, The Prostate.

[32]  D. Schrag,et al.  Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis , 2015, Gut.

[33]  A. DeMichele,et al.  Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study. , 2015, The Lancet. Oncology.

[34]  K. Washington,et al.  Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions , 2008, Cancer.

[35]  P. Zhang,et al.  Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours , 2015, Gut.

[36]  Jun Yu,et al.  Dysregulation of cellular signaling in gastric cancer. , 2010, Cancer letters.

[37]  E. Greer,et al.  Histone methylation: a dynamic mark in health, disease and inheritance , 2012, Nature Reviews Genetics.

[38]  J. Weinstein,et al.  Multifactorial Regulation of E-Cadherin Expression: An Integrative Study , 2010, Molecular Cancer Therapeutics.

[39]  P. A. Futreal,et al.  Emerging patterns of somatic mutations in cancer , 2013, Nature Reviews Genetics.

[40]  M. Ghosh,et al.  Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk. , 2013, Genes & cancer.

[41]  G. Hu,et al.  Epithelial-mesenchymal transition and cell cooperativity in metastasis. , 2009, Cancer research.

[42]  Wei Jiang,et al.  Histone H3K27me3 demethylases KDM6A and KDM6B modulate definitive endoderm differentiation from human ESCs by regulating WNT signaling pathway , 2012, Cell Research.

[43]  Russell J. Taylor,et al.  Wnt/β-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4 , 2012, Proceedings of the National Academy of Sciences.

[44]  F. Peng,et al.  Aurora kinase A suppresses metabolic stress-induced autophagic cell death by activating mTOR signaling in breast cancer cells , 2014, OncoTarget.

[45]  Ivan G. Costa,et al.  Replicative senescence is associated with nuclear reorganization and with DNA methylation at specific transcription factor binding sites , 2015, Clinical Epigenetics.

[46]  Paolo Bechi,et al.  Genomic and genetic alterations influence the progression of gastric cancer. , 2011, World journal of gastroenterology.

[47]  Genetic variation rs10484761 on 6p21.1 derived from a genome-wide association study is associated with gastric cancer survival in a Chinese population. , 2014, Gene.

[48]  A. Godwin,et al.  Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion , 2014, Oncogene.

[49]  A. Sonnenberg,et al.  The stomach in health and disease , 2015, Gut.

[50]  Lei Han,et al.  AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression. , 2013, Cancer research.

[51]  Yusuke Nakamura,et al.  Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer , 2008, Nature Genetics.

[52]  Atif Shahab,et al.  Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. , 2007, Cell stem cell.

[53]  Shuji Ogino,et al.  Aurora-A expression is independently associated with chromosomal instability in colorectal cancer. , 2009, Neoplasia.

[54]  Jeffrey Ecsedy,et al.  The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas , 2013, Cancer.

[55]  G. Schwartz,et al.  MLN-8237: A dual inhibitor of aurora A and B in soft tissue sarcomas , 2016, Oncotarget.

[56]  K. Henkels,et al.  A non-mitotic role for Aurora kinase A as a direct activator of cell migration upon interaction with PLD, FAK and Src , 2015, Journal of Cell Science.